Latest From Nuvaira Inc.
Device funding increased 123% to $1.6 billion in Q2, and M&A activity was overshadowed by Medtronic’s massive $47 billion acquisition of Covidien. Diagnostics fundraising dropped slightly to $522 million, and there were multiple takeovers of life sciences companies.
Hanson Gifford III and Mark Deem, two co-founders of the prolific medtech incubator The Foundry, have had a hand in generating more than $2 billion in value for medtech investors and entrepreneurs during the incubator’s 15-plus years. At IN³ Medical Device 360° in Dublin, the pair shared some of the lessons they have learned along the way.
Hanson Gifford III and Mark Deem, two co-founders of the prolific medtech incubator The Foundry, have had a hand in generating more than $2 billion in value for medtech investors and entrepreneurs over the incubator’s 15-plus years. At IN3 Dublin, the pair shared some of the lessons they have learned along the way.
Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Recent Financings Of Private Companies column provides a comprehensive monthly review of emerging life science companies that have received venture funding, including companies within the In Vitro Diagnostics, Medical Devices, and Pharmaceuticals sectors. This month’s column covers deals announced March through April 2014.
- Radiofrequency Devices
- Therapeutic Areas
- Respiratory, Pulmonary
- Innovative Pulmonary Solutions Inc.
- Holaira Inc.
- North America
- Parent & Subsidiaries
- Nuvaira Inc.
- Senior Management
Dennis Wahr, MD, Pres. & CEO
Kari Kubesh, CFO
Martin Mayse, MD, CTO
Lisa Rogen, SVP, Global Market Dev.
- Contact Info
Phone: (763) 450-2800
3750 Annapolis Lane N, Ste. 105
Minneapolis, MN 55447
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.